NeuroBo Pharmaceuticals
as a novel dual agonist for the treatment of obesity | NeuroBo Pharmaceuticals
Deck date
December 2023
Slide
15 of 25
Similar slides by NeuroBo Pharmaceuticals
Investor Presentation
January 2024
Other recent decks by NeuroBo Pharmaceuticals
Investor Presentation
January 2024
Securities Offering
October 2022
Investor Presentation
March 2021
Search Thousands of Presentations by World Leading Companies